UNIVERSITY OF WASHINGTON
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 1861-01-01
- Employees
- 10K
- Market Cap
- -
Olaparib for the Treatment of Castration Resistant Prostate Adenocarcinoma
Phase 2
Terminated
- Conditions
- Castration-Resistant Prostate CarcinomaProstate Adenocarcinoma
- Interventions
- First Posted Date
- 2021-07-06
- Last Posted Date
- 2025-01-01
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 2
- Registration Number
- NCT04951492
- Locations
- πΊπΈ
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Bolster: Caregiver App to Reduce Duration of Untreated Psychosis
Not Applicable
Recruiting
- Conditions
- Caregiver to a Young Adult With Early Psychosis
- Interventions
- Behavioral: ControlBehavioral: Bolster
- First Posted Date
- 2021-07-02
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 60
- Registration Number
- NCT04949542
- Locations
- πΊπΈ
Behavioral Research in Technology and Engineering Center, Health Sciences, UW Medical Center, Seattle, Washington, United States
Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence
Not Applicable
Recruiting
- Conditions
- Endometrial Cancer
- Interventions
- Behavioral: Facilitated group support
- First Posted Date
- 2021-06-18
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 252
- Registration Number
- NCT04930159
- Locations
- πΊπΈ
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
πΊπΈLouisiana State University - New Orleans, New Orleans, Louisiana, United States
πΊπΈUniversity of Alabama, Birmingham, Alabama, United States
Nudges for Opioid Reduction After Major Surgery Trial
Not Applicable
Active, not recruiting
- Conditions
- Surgery
- Interventions
- Behavioral: Electronic Medical Record Based Discharge Medication Order Set
- First Posted Date
- 2021-06-16
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 484
- Registration Number
- NCT04927351
- Locations
- πΊπΈ
University of Washington, Seattle, Washington, United States
A Guide to Conservative Care
Not Applicable
Completed
- Conditions
- DialysisPatient EngagementEnd Stage Renal DiseaseDecision AidEnd-of-life Care
- Interventions
- Other: A Guide to Conservative Care
- First Posted Date
- 2021-06-09
- Last Posted Date
- 2022-06-24
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 92
- Registration Number
- NCT04919941
- Locations
- πΊπΈ
VA Puget Sound Health Care System, Seattle, Washington, United States
πΊπΈUniversity of Washington Medicine, Seattle, Washington, United States
Home Air in Agriculture: Pediatric Intervention Trial
Not Applicable
Completed
- Conditions
- Asthma in Children
- Interventions
- Device: HEPA air cleaner
- First Posted Date
- 2021-06-09
- Last Posted Date
- 2021-06-09
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 71
- Registration Number
- NCT04919915
- Locations
- πΊπΈ
Yakima Valley Farmworkers Clinic, Yakima, Washington, United States
PRISM Race and Communication Pilot RCT
Phase 2
Recruiting
- Conditions
- Discrimination, RacialChronic IllnessBias, RacialCommunication
- Interventions
- Behavioral: Promoting Resilience in Stress Management (PRISM)
- First Posted Date
- 2021-06-07
- Last Posted Date
- 2023-12-04
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 60
- Registration Number
- NCT04915079
- Locations
- πΊπΈ
University of Washington - Harborview Medical Center, Seattle, Washington, United States
Improving Asthma Care Together (IMPACT): A Shared Management Pilot Study
Not Applicable
Completed
- Conditions
- Asthma in Children
- Interventions
- Behavioral: Improving Asthma Care Together (IMPACT)
- First Posted Date
- 2021-06-01
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 104
- Registration Number
- NCT04908384
- Locations
- πΊπΈ
University of Washington School of Nursing, Seattle, Washington, United States
Hypertension Prevention Program, Implementation and Scale up- a Hybrid Effectiveness Implementation Study
Not Applicable
- Conditions
- Health BehaviorHypertensionDietary Modification
- Interventions
- Behavioral: Behavioral Intervention Group
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2021-05-26
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 500
- Registration Number
- NCT04899648
Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
Phase 2
Recruiting
- Conditions
- Recurrent Multiple MyelomaRefractory Multiple Myeloma
- Interventions
- Drug: CarfilzomibDrug: DexamethasoneBiological: IsatuximabDrug: PomalidomideProcedure: Bone Marrow BiopsyProcedure: Bone Marrow AspirationProcedure: Skeletal Survey X-RayProcedure: Computed TomographyProcedure: Positron Emission TomographyProcedure: Magnetic Resonance Imaging
- First Posted Date
- 2021-05-12
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 37
- Registration Number
- NCT04883242
- Locations
- πΊπΈ
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Β© Copyright 2025. All Rights Reserved by MedPath